Finepoint Capital »

Concord Acquisition Corp A shares owned by Finepoint Capital

Quarter-by-quarter ownership of Concord Acquisition Corp A (CNDAW) shares owned by Finepoint Capital from 13F filings

Historical chart of Finepoint Capital investment in Concord Acquisition Corp A

Tip: Access up to 7 years of quarterly data

All positions including Concord Acquisition Corp A held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Concord Acquisition Corp A by Finepoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $45k 408k 0.11
2024-03-31 $45k 408k 0.11
2023-09-30 $43k 408k 0.10
2023-06-30 $16k 408k 0.04
2023-03-31 $29k 408k 0.07
2022-12-31 $47k 408k 0.12
2022-09-30 $86k 408k 0.21
2022-06-30 $90k 408k 0.22
2022-03-31 $243k 408k 0.60
2021-12-31 $388k 408k 0.95

More positions owned by Finepoint Capital

Qxo Com New (QXO)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Liberty Broadband Corp Com Ser C (LBRDK)
Revolution Medicines (RVMD)
Argenx SE Sponsored Adr (ARGX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Travere Therapeutics (TVTX)
Springworks Therapeutics (SWTX)
MoonLake Immunotherapeutics Class A Ord (MLTX)
Sarepta Therapeutics (SRPT)
Galapagos Nv Spon Adr (GLPG)
Arvinas Ord (ARVN)
ACADIA Pharmaceuticals (ACAD)
Cytokinetics Com New (CYTK)

View all positions for Finepoint Capital

Top funds holding Concord Acquisition Corp A

Clear Street
Rivernorth Capital Management
Flow Traders US
Ancora Advisors
David W. Seeley

View all funds holding Concord Acquisition Corp A